Safety and Efficacy of Stereotactic Body Radiotherapy in Ultracentral Lung Tumors Using a Risk-optimized Fractionation Scheme

ISSN
1525-7304
Date Issued
2021
Author(s)
Regnery, Sebastian
Eichkorn, Tanja
Weykamp, Fabian
Held, Thomas
Weusthof, Katharina
Dinges, Lisa-Antonia
Winter, Hauke
Thomas, Michael
Debus, Jürgen
Adeberg, Sebastian
Hörner-Rieber, Juliane
DOI
10.1016/j.cllc.2020.11.003
Abstract
Delivery of stereotactic body radiotherapy (SBRT) to ultracentral lung tumors remains a major challenge, with potentially excessive SBRT-related toxicity. This study investigates a risk-optimized approach to ultracentral SBRT in an elderly and comorbid patient cohort.